BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3514666)

  • 1. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.
    Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G
    J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc gamma receptors and HLA-DR antigens on thymus cells in myasthenia gravis.
    Gilhus NE; Matre R
    J Neuroimmunol; 1986 Jan; 10(3):271-8. PubMed ID: 2934405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic lymphocytes in myasthenia gravis.
    Birnbaum G; Tsairis P
    Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HL-A antigens on hyperplastic and neoplastic thymic tissue.
    Naeim F; Stoddard A; Fritze D; Herrmann C; Zeller E; Walford RL
    Cancer Res; 1974 Mar; 34(3):654-6. PubMed ID: 4812266
    [No Abstract]   [Full Text] [Related]  

  • 6. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
    van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO
    Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
    Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoma: an immunohistochemical study.
    Chan WC; Zaatari GS; Tabei S; Bibb M; Brynes RK
    Am J Clin Pathol; 1984 Aug; 82(2):160-6. PubMed ID: 6380266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro growth and phenotypic characterization of mesodermal-derived and epithelial components of normal and abnormal human thymus.
    Singer KH; Harden EA; Robertson AL; Lobach DF; Haynes BF
    Hum Immunol; 1985 Jul; 13(3):161-76. PubMed ID: 3874195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered intrathymic T-cell repertoire in human myasthenia gravis.
    Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
    Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis.
    Aarli JA; Heimann P; Matre R; Thunold S; Tönder O
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thymus in myasthenia gravis. Evidence for altered cell populations.
    Abdou NI; Lisak RP; Zweiman B; Abrahamsohn I; Penn AS
    N Engl J Med; 1974 Dec; 291(24):1271-5. PubMed ID: 4279335
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis.
    Marx A; Kirchner T; Greiner A; Müller-Hermelink HK; Schalke B; Osborn M
    Lancet; 1992 Mar; 339(8795):707-8. PubMed ID: 1372058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations.
    Spurkland A; Gilhus NE; Rønningen KS; Aarli JA; Vartdal F
    Tissue Antigens; 1991 Feb; 37(2):90-3. PubMed ID: 2057938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells.
    Matsumoto Y; Furuya A; Kobayashi T; Tsukagoshi H
    J Neurol Sci; 1986 Sep; 75(2):121-33. PubMed ID: 3760907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.
    Fujii Y; Hayakawa M; Nakahara K
    J Neurol; 1992 Feb; 239(2):82-8. PubMed ID: 1552308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.
    Shirai T; Miyata M; Nakase A; Itoh T
    Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.